Degradation of troponin I (TnI) by calpain occurs with myocardial stunning in ischemia-reperfusion injury. Glucocorticoids attenuate myocardial ischemia-reperfusion injury, but their effect on TnI degradation is unknown. A piglet model was used to test the hypotheses that cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) are associated with TnI degradation and that TnI alterations could be prevented by glucocorticoid treatment. Piglets were cooled to 18°C, subjected to 2 h of circulatory arrest, rewarmed to 37°C, and allowed to recover for 2 h. Methylprednisolone was administered 6 h before surgery (3 0 mg/kg) and at initiation of CPB (30 mg/kg). The untreated group received saline. Left ventricular tissue was collected after recovery and analyzed by Western blot for TnI, calpain, and calpastatin (the natural inhibitor of calpain). CPB/ DHCA animals had 27.4 Ϯ 0.2% of total detected TnI present in degraded form. Glucocorticoid treatment significantly decreased the percentage of degraded TnI (12.0 Ϯ 0.1%, p Ͻ 0.05). Calpain I and calpain II increased after CPB/DHCA compared with non-CPB/DHCA controls (p Ͻ 0.05), with or without glucocorticoid treatment. Calpastatin significantly decreased in untreated CPB/DHCA animals compared with non-CPB/DHCA controls (p Ͻ 0.05), but levels were preserved by glucocorticoids. Glucocorticoids were associated with preservation of maximum rate of increase of left ventricular pressure at 95 Ϯ 10% of baseline, whereas maximum rate of increase of left ventricular pressure decreased to 62 Ϯ 12% of baseline without steroids. TnI degradation occurs after CPB/DHCA in neonatal pigs. Reduction in reperfusion injury by glucocorticoids may depend partly on preservation of calpastatin activity and intact TnI. Surgery for congenital heart disease often requires CPB and periods of myocardial ischemia. A period of total circulatory arrest may also be required, particularly for complex neonatal repairs. In the first 8 to 12 h after CPB there is a transient decrease in myocardial function consistent with reperfusion injury (1). Although the exact mechanisms of CPB-related myocardial injury remain unknown, there is substantial evidence that CPB can produce a systemic inflammatory response or free radical injury (2-4). The cysteine protease calpain exists in the myocardium in two isoforms, calpain I and calpain II. Recently, it has been suggested that activation of calpain during reperfusion of ischemic myocardium may be a key event in the process of myocardial stunning (5, 6). Calcium influx that occurs when ischemic myocardium is reperfused promotes dissociation of calpain from its inhibitor, calpastatin. Activated calpain then degrades the contractile regulatory protein TnI by cleavage at the C-terminus to form the fragment . Additional systematic degradation of the amino terminus can lead to subsequent smaller degradation products. Degradation products and covalent complexes of TnI have been observed in humans with ischemic heart disease (7,8).The use of glucocorticoids ...